Lung cancer
Lung cancer is the most commonly diagnosed cancer in China. The country’s leading cancer centers have extensive experience with minimally invasive surgery for small nodules, molecular testing, targeted therapy and immunotherapy.
How leading Chinese hospitals approach serious conditions, and where to go.
Lung cancer is the most commonly diagnosed cancer in China. The country’s leading cancer centers have extensive experience with minimally invasive surgery for small nodules, molecular testing, targeted therapy and immunotherapy.
Nasopharyngeal carcinoma is far more common in southern China than in most of the world, and Sun Yat-sen University Cancer Center in Guangzhou has led many of the trials that define its treatment internationally.
Fuwai Hospital and Zhongshan Hospital rank first and second in China for cardiovascular medicine and perform very large numbers of coronary procedures, from stenting to bypass surgery, including complex and multivessel cases.
China treats more liver cancer than any other country, and its leading centers combine surgery, liver transplantation, interventional therapy and modern drug treatment for hepatocellular carcinoma.
Breast cancer is the most common cancer among women in China. Leading Chinese cancer centers offer breast-conserving surgery, reconstruction, molecular subtyping and the full range of modern drug treatment.
China accounts for about half of the world’s esophageal cancer cases, most of them squamous cell carcinoma. Chinese centers lead in endoscopic treatment of early tumors, minimally invasive esophagectomy and combined chemoradiotherapy.
Leukemia is a group of blood cancers. Shanghai’s Ruijin Hospital pioneered the treatment that turned acute promyelocytic leukemia into a curable disease, and Chinese centers offer chemotherapy, targeted drugs, stem cell transplantation and CAR-T therapy.
Beijing Tiantan Hospital and Huashan Hospital rank first and second in China for neurosurgery and operate on very large numbers of gliomas, meningiomas, pituitary and skull-base tumors every year.
Beijing Tiantan Hospital leads China’s national stroke research: its trials of combined antiplatelet treatment changed stroke-prevention guidelines worldwide. International patients come for second opinions, secondary prevention, and treatment of aneurysms and narrowed arteries.
Congenital heart defects are the most common birth defects. Fuwai Hospital ranks first in China for cardiac surgery and the Children’s Hospital of Fudan University first for pediatrics; both treat children and adults with simple and complex defects.
Cataract surgery is one of the most common operations in the world. Zhongshan Ophthalmic Center in Guangzhou ranks first in China for ophthalmology and has developed widely used cataract techniques.
Lupus is a chronic autoimmune disease that can affect the skin, joints, kidneys and other organs. Peking Union Medical College Hospital ranks first in China for rheumatology and leads the country’s national lupus registry and treatment guidelines.
Ruijin Hospital ranks first in China for endocrinology and hosts the Shanghai Institute of Endocrine and Metabolic Diseases. Patients come for assessment of complex or unusual diabetes, complications and, if they wish, integrated traditional Chinese medicine.
Peking University Third Hospital ranks first in China for sports medicine. Its Institute of Sports Medicine treats athletes and active people with ligament, meniscus and cartilage injuries using arthroscopic surgery and structured rehabilitation.
Microtia is an underdeveloped outer ear present from birth. Shanghai Ninth People’s Hospital ranks first in China for plastic surgery and is a leading center for ear reconstruction in children and adults.